A detailed history of Bank Of Nova Scotia transactions in Bio Techne Corp stock. As of the latest transaction made, Bank Of Nova Scotia holds 20,168 shares of TECH stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,168
Previous 11,819 70.64%
Holding current value
$1.36 Million
Previous $846,000 90.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$70.96 - $82.35 $592,445 - $687,540
8,349 Added 70.64%
20,168 $1.61 Million
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $282,894 - $383,219
-4,554 Reduced 27.81%
11,819 $846,000
Q1 2024

May 14, 2024

SELL
$65.98 - $77.09 $10,094 - $11,794
-153 Reduced 0.93%
16,373 $1.15 Million
Q4 2023

Feb 12, 2024

BUY
$52.83 - $78.22 $101,063 - $149,634
1,913 Added 13.09%
16,526 $1.28 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $122,953 - $162,833
1,821 Added 14.24%
14,613 $994,000
Q2 2023

Aug 03, 2023

BUY
$73.76 - $85.98 $168,025 - $195,862
2,278 Added 21.67%
12,792 $1.04 Million
Q1 2023

May 11, 2023

BUY
$71.62 - $86.62 $304,385 - $368,135
4,250 Added 67.85%
10,514 $780,000
Q4 2022

Feb 09, 2023

BUY
$80.67 - $352.29 $430,213 - $1.88 Million
5,333 Added 572.82%
6,264 $519,000
Q3 2022

Nov 10, 2022

SELL
$282.54 - $391.85 $2,542 - $3,526
-9 Reduced 0.96%
931 $264,000
Q2 2022

Aug 05, 2022

SELL
$322.67 - $449.65 $557,251 - $776,545
-1,727 Reduced 64.75%
940 $326,000
Q1 2022

May 09, 2022

SELL
$353.85 - $487.79 $2.54 Million - $3.5 Million
-7,167 Reduced 72.88%
2,667 $1.16 Million
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $2.16 Million - $2.49 Million
4,735 Added 92.86%
9,834 $5.1 Million
Q3 2021

Nov 12, 2021

BUY
$444.87 - $538.88 $2.27 Million - $2.75 Million
5,099 New
5,099 $2.47 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.65B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.